Alerts will be sent to your verified email
Verify EmailALKEM
Alkem Laboratories
|
Glenmark Pharma
|
Aurobindo Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
185.0 . | 13.0 . | 861.0 . |
Number of ANDA's Approved By USFDA
|
158.0 . | 25.0 . | 719.0 . |
Number of ANDA's Filed in Europe
|
18.0 | n/a | n/a |
Number of ANDA's Approved in Europe
|
12.0 | n/a | n/a |
Number of ANDA's Filed in Australia
|
42.0 | n/a | n/a |
Number of ANDA's Approved by Australia
|
32.0 | n/a | n/a |
Domestic Sales Growth - YoY
|
73.0 % | 10.3 % | n/a |
R&D as a % of Total Sales
|
5.0 % | 7.3 % | 5.05 % |
Financials
|
|||
5 yr Average ROE
|
17.38 % | 4.18 % | 13.97 % |
5yr average Equity Multiplier
|
1.39 | 1.88 | 1.51 |
5yr Average Asset Turnover Ratio
|
0.86 | 0.79 | 0.71 |
5yr Avg Net Profit Margin
|
14.54 % | 2.73 % | 12.77 % |
Price to Book
|
4.88 | 6.59 | 1.92 |
P/E
|
27.03 | 55.71 | 17.99 |
5yr Avg Cash Conversion Cycle
|
-61.46 Days | -121.67 Days | -49.62 Days |
Inventory Days
|
56.11 Days | 40.44 Days | 59.48 Days |
Days Receivable
|
44.62 Days | 36.38 Days | 28.34 Days |
Days Payable
|
122.42 Days | 201.37 Days | 115.71 Days |
5yr Average Interest Coverage Ratio
|
24.48 | 3.48 | 43.78 |
5yr Avg ROCE
|
22.76 % | 16.29 % | 16.69 % |
5yr Avg Operating Profit Margin
|
18.44 % | 15.62 % | 19.28 % |
5 yr average Debt to Equity
|
0.18 | 0.49 | 0.21 |
5yr CAGR Net Profit
|
6.44 % | n/a | 2.21 % |
5yr Average Return on Assets
|
12.47 % | 1.86 % | 9.18 % |
Shareholdings
|
|||
Promoter Holding
|
53.04 % | 46.65 % | 51.82 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 17.08 % |
Change in Promoter Holding (3 Yrs)
|
-4.1 % | 0.0 | -0.01 % |
Change in Mutual Fund Holding (3 Yrs)
|
8.82 % | 9.74 % | 9.14 % |
Alkem Laboratories
|
Glenmark Pharma
|
Aurobindo Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|